Literature DB >> 6753751

Dipeptidyl peptidase IV inhibits the polymerization of fibrin monomers.

R Mentlein, E Heymann.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6753751     DOI: 10.1016/0003-9861(82)90556-2

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


× No keyword cloud information.
  10 in total

Review 1.  Cardiovascular impact of drugs used in the treatment of diabetes.

Authors:  Chris R Triggle; Hong Ding
Journal:  Ther Adv Chronic Dis       Date:  2014-11       Impact factor: 5.091

2.  Dipeptidyl peptidase IV in mammalian lungs.

Authors:  E Krepela; J Viccar; L Zizková; E Kasafírek; Z Kolár; V Lichnovský
Journal:  Lung       Date:  1985       Impact factor: 2.584

Review 3.  [Has dipeptidyl peptidase IV an effect on blood pressure and coagulation?].

Authors:  E Heymann; R Mentlein
Journal:  Klin Wochenschr       Date:  1984-01-02

Review 4.  DPP4 Activity, Hyperinsulinemia, and Atherosclerosis.

Authors:  Kaitlin M Love; Zhenqi Liu
Journal:  J Clin Endocrinol Metab       Date:  2021-05-13       Impact factor: 5.958

Review 5.  The role of DPP4 activity in cardiovascular districts: in vivo and in vitro evidence.

Authors:  L Pala; C M Rotella
Journal:  J Diabetes Res       Date:  2013-06-18       Impact factor: 4.011

6.  Loss of DPP4 activity is related to a prothrombogenic status of endothelial cells: implications for the coronary microvasculature of myocardial infarction patients.

Authors:  Paul A J Krijnen; Nynke E Hahn; Ivana Kholová; Umit Baylan; Jessica A Sipkens; Floris P van Alphen; Alexander B A Vonk; Suat Simsek; Christof Meischl; Casper G Schalkwijk; Jaap D van Buul; Victor W M van Hinsbergh; Hans W M Niessen
Journal:  Basic Res Cardiol       Date:  2011-12-14       Impact factor: 17.165

Review 7.  The nonglycemic actions of dipeptidyl peptidase-4 inhibitors.

Authors:  Na-Hyung Kim; Taeyang Yu; Dae Ho Lee
Journal:  Biomed Res Int       Date:  2014-07-21       Impact factor: 3.411

8.  Plasma DPP4 activity is associated with no-reflow and major bleeding events in Chinese PCI-treated STEMI patients.

Authors:  Jing Wei Li; Yun Dai Chen; Wei Ren Chen; Jing Jing; Jie Liu; Yong Qiang Yang
Journal:  Sci Rep       Date:  2016-12-21       Impact factor: 4.379

9.  Linagliptin Regulates the Mitochondrial Respiratory Reserve to Alter Platelet Activation and Arterial Thrombosis.

Authors:  Yi Li; Rong Li; Ziqian Feng; Qin Wan; Jianbo Wu
Journal:  Front Pharmacol       Date:  2020-11-30       Impact factor: 5.810

Review 10.  Cardiovascular protection by DPP-4 inhibitors in preclinical studies: an updated review of molecular mechanisms.

Authors:  Esraa M Zakaria; Walaa M Tawfeek; Mohamed H Hassanin; Mohammed Y Hassaballah
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2022-08-10       Impact factor: 3.195

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.